Pe 22 28 Peptide

High standards·Traceability·Scalability

 Please feel free to contact Xi'an Sonwu Biotech Co., Ltd. for any products you are interested in.

Send Inquiry Now

PE 22 28 peptide is a synthetic heptapeptide biomodulator derived from the precursor protein Sortilin. It is currently the most representative antagonist raw material targeting the TREK 1 ion channel in neuropharmacology research and is widely recognized as a core breakthrough for developing novel and rapid antidepressant interventions.

As a heptapeptide derived from Spadin, this novel antidepressant candidate raw material, which has attracted much attention in the field of neuroscience research, is a highly precise neurofunctional remodeling molecule. Its development marks a shift in antidepressant research from the traditional monoamine neurotransmitter theory to a deeper logic of ion channel regulation. In the international high-purity API trade, this peptide, with its extremely simple sequence structure, excellent biological activity, and clear neuroregenerative potential, has become a benchmark raw material in neuroscience laboratories and cutting-edge pharmaceutical research and development. If you are interested in pe 22 28 peptide suppliers , you can contact Xi'an Sonwu Biotech Co., Ltd.

Xi'an Sonwu Biotech Co., Ltd is a peptide raw material supplier with peptide technology at its core and an international market orientation. Xi'an Sonwu specialize in the R&D, production, and global supply of functional peptides and polypeptide raw materials, serving multiple application areas including muscle building, beauty, hair growth, weight management, nootropics and pharmaceuticals raw materials.

Xi'an Sonwu products have been widely used in the R&D and industrialization projects of customers worldwide.Based on this, Xi'an Sonwu have received a lot of feedback on Sonwu products. Therefore, if you need it,please contact Xi'an Sonwu.

Xi'an Sonwu not only provides large-scale production services but can also provide sample packages to customers first.

Xi'an Sonwu not only supplies PE 22 28, but also customizes products according to customer needs. In addition, Sonwu offers customized packaging services, repackaging products according to customer requirements.

So any customers could customize package they want. And items below can be supplied.

1. Customized bottles(size, color, material, style)
2. Customized packaging(vacuum foil packaging, box, drum)
3. Customized label(paint film, matte film, optical mask)

1. Breakthrough Rapid-Acting Antidepressant Benefits

PE-22-28's most revolutionary benefit lies in its triggering of a rapid-acting antidepressant mechanism. While traditional SSRIs typically take weeks or even months to show clinical benefits, it has demonstrated the ability to reverse depressive-like behaviors in a very short time (even hours to days) in laboratory studies. This benefit stems from its direct intervention in specific brain signaling pathways, rather than relying on long-term serotonin level remodeling. For research institutions aiming to develop treatment-resistant depression or requiring urgent interventions, this ingredient provides a novel biological pathway that transcends the traditional drug lag, significantly improving the efficiency of neural repair.

2. Significantly Promotes Hippocampal Neurogenesis and Synaptic Plasticity

Beyond mood regulation, this peptide also demonstrates profound benefits in neurogeneration. It significantly upregulates the expression of brain-derived neurotrophic factor (BDNF) in the hippocampus, a key protein for maintaining neuronal survival, differentiation, and synaptic connections. This benefit not only helps repair nerve damage caused by long-term stress but also enhances cognitive function and learning/memory abilities. This "structural repair" benefit elevates it beyond simple chemical balance regulation, making it an advanced biological tool capable of physically strengthening the resilience of the brain's neural networks, providing crucial experimental support for neurodegenerative research.

3. Superior Biostability and Targeted Safety

As a derivative sequence of Spadin, its core benefits also include high stability under physiological conditions. Compared to its parent peptide, this streamlined heptapeptide sequence (Gln-Arg-Ala-Lys-Leu-Gln-Ala) exhibits better resistance to protease degradation, meaning it can maintain longer-lasting bioactivity in experimental studies. Furthermore, due to its mechanism of action highly targeting specific potassium ion channels, it avoids the widespread side effects common in traditional antidepressant interventions (such as interference with the cardiovascular or metabolic systems). This precise targeting ensures high purity of research data, making it an ideal API choice for developing next-generation, highly safe neuroactive ingredients.

1. Mechanism of Neuroexcitability Regulation by Blocking TREK 1 Potassium Channels

The core mechanism by which PE-22-28 peptide exerts its effect lies in its highly efficient blocking effect on two-pore potassium channel, K2P2.1. This channels are often considered a "brake" on neuronal excitability; in a depressive state, these channels tend to be overactive, leading to neuronal hyperpolarization and suppressed firing activity. PE-22-28 precisely shuts down this "potassium efflux gate" by binding to specific sites on this channel. This mechanism rapidly increases the excitability of neurons in the dorsal raphe nucleus (DRN) and hippocampus, enhancing the firing frequency of serotonergic neurons. This intervention, based on the underlying logic of ion flow, bypasses complex receptor metabolism processes, achieving direct physical correction of the speed and intensity of neural signal transmission.

2. Activation of Downstream CREB Signaling Pathway and Neurotrophic Cascade

At the intracellular signal transduction level, its mechanism of action involves the deep activation of the CREB (cyclic adenosine monophosphate effector element-binding protein) pathway. When the TREK-1 channel is blocked, the depolarization state within neurons triggers a phosphorylation cascade of kinases (such as MAPK/ERK), ultimately acting on transcription factors in the cell nucleus. This mechanism induces the transcription of numerous neurotrophic genes, thereby initiating the remodeling of postsynaptic membrane receptors and the regeneration of dendritic spines. This ion channel-mediated epigenetic regulation constitutes the molecular basis for its sustained repair effect, achieving a functional closed loop from transient membrane potential changes to long-term protein synthesis, providing a microscopic perspective for understanding how the brain achieves emotional homeostasis at a higher level.

1. Xi'an Sonwu Biotech Co . Itd has established a complete technology platform, covering peptide molecular design, custom synthesis, precision purification, structural identification, and quality control.

2. It strictly adheres to international quality management standards, ensuring that its peptide raw materials meet the high-end requirements of overseas customers in terms of purity, stability, and batch consistency.

3. Looking to the future, it will continue to deepen peptide technology innovation, expand the global cooperation network, and strive to become a trusted long-term peptide raw material solution partner for international customers.

HALAL

HACCP

CERES

ISO9001

ISO14001

ISO22000

 

In addition to guaranteeing the product quality, the other most vital thing is clients could receive the goods smoothly. So, Xi'an Sonwu supply all kinds of couriers according to different needs.

Q1: Why is the heptapeptide structure PE 22 28 peptide more valuable for research than its prototype, Spadin (a 17-peptide)?

A: The key lies in molecular efficiency and stability. PE-22-28 is the C-terminal active fragment of Spadin, retaining its full binding affinity to TREK-1. However, due to its shorter peptide chain, it has higher solubility and is less susceptible to degradation by endogenous peptidases in tissues. In pharmacokinetic modeling, it exhibits better bioavailability, which is crucial for experimental studies requiring concentrations in the central nervous system.

Q2: How can biochemical indicators confirm that PE-22-28 produced the expected effect in the experimental model?

A: The most direct indicator is to detect the expression levels of p-CREB (phosphorylated CREB) and BDNF in hippocampal tissue. Since the mechanism of action of PE-22-28 ultimately converges on the upregulation of these two signaling proteins, if these indicators are observed to be significantly higher than those in the control group after treatment, it proves that the downstream cascade mediated by the TREK 1 channel has been successfully activated. Furthermore, the increase in neuronal firing frequency in electrophysiological experiments is also a key gold standard for verifying its API activity.

Email:  sales02@sonwu.com

Hot Tags: pe 22 28 peptide, China pe 22 28 peptide manufacturers, suppliers, factory